Key facts
- Notable investors include Fuguang Investment.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Paijin Biopharmaceuticals
- ·The full record, as it builds
Funding rounds
No funding rounds for Paijin Biopharmaceuticals are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Paijin Biopharmaceuticals
Operator of a biotechnology company based in Hangzhou, China.
- Sector
- Healthcare
- HQ
- Hangzhou, China
- Founded
- 2024
- Ownership
- Privately Held (backing)
Paijin Biopharmaceuticals doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Paijin Biopharmaceuticals shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Paijin Biopharmaceuticals in its N-PORT filings yet. We sweep new filings monthly.